Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity

The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia. We reported comparative in vitro studies of combination effects of different cephalosporins (i.e., cefazolin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Microbiol
Autores principales: Tang, Hung-Jen, Lai, Chih-Cheng, Chen, Chi-Chung, Zhang, Chun-Cheng, Weng, Tzu-Chieh, Yu, Wen-Liang, Chen, Hung-Jui, Chiu, Yu-Hsin, Ko, Wen-Chien, Chuang, Yin-Ching
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5435797/
https://ncbi.nlm.nih.gov/pubmed/28572795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2017.00884
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares